Functional characterization of late outgrowth endothelial progenitor cells in patients with end‐stage renal failure
Open Access
- 5 March 2014
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 27 (5) , 437-451
Abstract
Renal transplantation is potentially curative in renal failure, but long-term efficacy is limited by untreatable chronic rejection. Endothelial damage contributes to chronic rejection and is potentially repairable by circulating endothelial progenitor cells (EPC). The frequency and function of EPC are variably influenced by end-stage renal failure (ESRF). Here, we isolated and functionally characterized the late outgrowth EPC (LO-EPC) from ESRF patients to investigate their potential for endothelial repair. Patients with ESRF generated more LO-EPC colonies than healthy controls and had higher plasma levels of IL-1rα, IL-16, IL-6, MIF, VEGF, Prolactin, and PLGF. Patients' LO-EPC displayed normal endothelial cell morphology, increased secretion of PLGF, MCP-1, and IL-1β, and normal network formation in vitro and in vivo. They demonstrated decreased adhesion to extracellular matrix. Integrin gene profiles and protein expression were comparable in patients and healthy volunteers. In some patients, mesenchymal stem cells (MSC) were co-isolated and could be differentiated into adipocytes and osteocytes in vitro. This is the first study to characterize LO-EPC from patients with ESRF. Their behavior in vitro reflects the presence of elevated trophic factors; their ability to proliferate in vitro and angiogenic function makes them candidates for prevention of chronic rejection. Their impaired adhesion and the presence of MSC are areas for potential therapeutic intervention.Keywords
This publication has 67 references indexed in Scilit:
- Mesenchymal Stem Cells: Are We Ready for Clinical Application in Transplantation and Tissue Regeneration?Frontiers in Immunology, 2013
- Comparison of Endothelial Cell Phenotypic Markers of Late-Outgrowth Endothelial Progenitor Cells Isolated from Patients with Coronary Artery Disease and Healthy VolunteersTissue Engineering Part A, 2009
- Endothelial progenitor cell dysfunction in patients with progressive chronic kidney diseaseAmerican Journal of Physiology-Renal Physiology, 2009
- Release of proinflammatory mediators and expression of proinflammatory adhesion molecules by endothelial progenitor cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2009
- Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular DiseaseCirculation, 2009
- Homing and engraftment of progenitor cells: A prerequisite for cell therapyJournal of Molecular and Cellular Cardiology, 2008
- Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cellsClinical and Experimental Immunology, 2007
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Integrins: Versatility, modulation, and signaling in cell adhesionCell, 1992